HQ Team
March 14, 2026: A specific bacterium that causes severe gum disease can invade the bloodstream, travel to the heart, and directly trigger the scarring that leads to a dangerous irregular heartbeat, according to a study from Hiroshima University. The findings provide the first clear evidence of a microbial pathway linking oral health to atrial fibrillation (AFib), a condition affecting roughly 60 million people worldwide.
P, gingivalis and heart tissue damage
The research identifies Porphyromonas gingivalis (P. gingivalis), the primary pathogen in periodontitis, as a direct culprit in heart tissue damage. In mouse models, the bacterium migrated from an infected tooth to the heart’s left atrium, where it caused progressive fibrosis (scar tissue buildup). This scarring distorted the heart’s architecture and electrical system, making abnormal rhythms far more likely. Mice exposed to P. gingivalis were six times more likely to develop AFib after 18 weeks compared to uninfected controls.
The team corroborated the animal findings in humans. Analyzing heart tissue from 68 AFib patients who underwent surgery, they detected P. gingivalis DNA in greater quantities among those with severe gum disease. “The causal relationship between periodontitis and atrial fibrillation is still unknown, but the spread of periodontal bacteria through the bloodstream may connect these conditions,” said study first author Shunsuke Miyauchi, assistant professor at Hiroshima University.
AFib is a major global health threat, doubling from 33.5 million cases in 2010 to nearly 60 million by 2019. It increases stroke and heart failure risk. While past studies linked gum disease to a 30% higher risk of AFib, the exact mechanism was unclear. Inflammation was the leading theory, immune responses in the gums releasing harmful signals into the blood. This study suggests a more direct route: the bacteria themselves physically invade and colonize the heart.
P. gingivalis is a stealthy pathogen. It can invade human cells and evade destruction, allowing it to persist in the body. In the heart, the study found it triggered a spike in galectin-3 (a fibrosis biomarker) and Tgfb1 (a gene promoting scarring). Over time, this turned healthy heart muscle stiff and fibrous, creating the perfect substrate for erratic electrical signals.
The broader impact
The discovery reframes gum disease from a local oral issue to a systemic cardiovascular risk. “P. gingivalis invades the circulatory system via periodontal lesions and translocates to the left atrium, where its bacterial load correlates with the clinical severity of periodontitis,” Miyauchi explained. “Once there, it exacerbates atrial fibrosis, resulting in higher AFib inducibility.”
The practical implication is straightforward: preventing or treating periodontitis could be a novel strategy for AFib prevention. “Periodontal treatment, which can block the gateway of P. gingivalis translocation, may play an important role in AFib prevention and treatment,” the authors state. This adds a compelling cardiac reason to the standard advice—brush, floss, and see your dentist regularly.
The Hiroshima team is now investigating the precise molecular mechanisms of how P. gingivalis damages heart cells and is working to establish a formal medical-dental collaboration network in Japan to integrate oral and cardiovascular care.This study moves beyond statistical association to demonstrate a direct biological mechanism. For the millions with gum disease, treating it may no longer be just about saving teeth—it could be about protecting your heart’s rhythm.
